Consequently, Ag delivery to CD1c+ DCs may further enhance tumor‐specific CD4+ T‐cell responses, even though anti‐CLEC9A and anti‐DEC‐205 Abs promote CD4+ T‐cell responses similarly after uptake by CD141+ DCs.69 This evidence concerns the gene CLEC9A and neoplasm.